Research Spotlight

Posted April 17th 2020

Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.

Molly Szerlip M.D.

Molly Szerlip M.D.

Shah, P. B., F. G. P. Welt, E. Mahmud, A. Phillips, N. S. Kleiman, M. N. Young, M. Sherwood, W. Batchelor, D. D. Wang, L. Davidson, J. Wyman, S. Kadavath, M. Szerlip, J. Hermiller, D. Fullerton and S. Anwaruddin (2020). “Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.” JACC Cardiovasc Interv Apr 3. pii: S1936-8798(20)30867-0. [Epub ahead of print].

Full text of this article.

The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic


Posted April 17th 2020

Robotic Thoracic Surgery

Gary Schwartz, M.D.

Gary Schwartz, M.D.

Schwartz, G., M. Sancheti and J. Blasberg (2020). “Robotic Thoracic Surgery.” Surg Clin North Am 100(2): 237-248.

Full text of this article.

Minimally invasive surgery for diseases of the chest offsets the morbidity of painful thoracic incisions while allowing for meticulous dissection of major anatomic structures. This benefit translates to improved outcomes and recovery following the surgical management of benign and malignant esophageal pathologic condition, mediastinal tumors, and lung resections. This anatomic region is particularly amenable to a robotic approach given the fixed space and need for complex intracorporeal dissection. As robotic platforms continue to evolve, more complex thoracic surgical interventions will be facilitated, translating to improved outcomes for our patients.


Posted April 17th 2020

The definition of neuronopathic Gaucher disease.

Raphael Schiffmann M.D.

Raphael Schiffmann M.D.

Schiffmann, R., J. Sevigny, A. Rolfs, E. H. Davies, O. Goker-Alpan, M. Abdelwahab, A. Vellodi, E. Mengel, E. Lukina, H. W. Yoo, T. Collin-Histed, A. Narita, T. Dinur, S. Revel-Vilk, D. Arkadir, J. Szer, M. Wajnrajch, U. Ramaswami, E. Sidransky, A. Donald and A. Zimran (2020). “The definition of neuronopathic Gaucher disease.” J Inherit Metab Dis Apr 3. [Epub ahead of print].

Full text of this article.

Neuronopathic Gaucher disease (nGD) has a very wide clinical and genotypic spectrum. However, there is no consensus definition of nGD, including no description of how best to diagnostically separate the acute form-Gaucher type 2-from the subacute or chronic form-Gaucher type 3. In this article, we define the various forms of Gaucher disease with particular emphasis on the presence of gaze palsy in all patients with nGD. This consensus definition will help in both clinical diagnosis and appropriate patient recruitment to upcoming clinical trials


Posted April 17th 2020

Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians

Peter McCullough, M.D.

Peter McCullough, M.D.

Ronco, F., G. Tarantini and P. A. McCullough (2020). “Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians.” Rev Cardiovasc Med 21(1): 9-23.

Full text of this article.

Contrast-induced acute kidney injury (CI-AKI) is a serious complication that can affect outcome and prognosis of patients undergoing percutaneous diagnostic and interventional procedures in catheterization laboratories. There have been advancements in case definition and epidemiology. Additionally strategies have emerged that are positioned to have impact in the catheterization laboratory for patients undergoing cardiovascular procedures. The aim of this review is to provide the state-of-the-art of diagnosis, prevention and management of CI-AKI in interventional cardiology.


Posted April 17th 2020

The Layer Where the Coronary Arterial “Endarterectomy” Specimen Separates from the Underlying Artery

William C. Roberts M.D.

William C. Roberts M.D.

Roberts, C. S. and W. C. Roberts (2020). “The Layer Where the Coronary Arterial “Endarterectomy” Specimen Separates from the Underlying Artery.” Am J Cardiol 125(6): 999-1000.

Full text of this article.

Described herein is a patient who had a coronary endarterectomy at the time of coronary artery bypass grafting. Histologic study of cross-sections of the endarterectomy specimen disclosed that the layer of separation of the endarterectomy specimen from the underlying native artery was in the media. This layer or plane of excision is virtually always the media irrespective of the artery having the endarterectomy. The procedure might better be called “endomediaectomy?”